COMUNICADO: Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity (2)

Publicado 19/03/2018 18:51:20CET

10. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-285.

11. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.

12. Wright SM, Aronne LJ. Causes of obesity. Abdominal Imaging. 2012;37:730-732.

13. World Health Organization. Obesity and Overweight Factsheet no. 311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en. Last accessed: March 2018.

Further information Media: Katrine Sperling, +45-4442-6718, krsp@novonordisk.com Liz Skrbkova (US), +1-609-917-0632, lzsk@novonordisk.com Ken Inchausti (US), +1-609-786-8316, kiau@novonordisk.com Investors: Peter Hugreffe Ankersen, +45-3075-9085, phak@novonordisk.com Anders Mikkelsen, +45-3079-4461, armk@novonordisk.com Christina Kjaer, +45-3079-3009, cnje@novonordisk.com

Mejora la comunicación de tu empresa con Europa Press Comunicación

Mejora la comunicación de tu empresa con Europa Press Comunicación